42 results on '"Pathologie Groep Brosens"'
Search Results
2. Long-term restoration of bowel continuity after rectal cancer resection and the influence of surgical technique: A nationwide cross-sectional study
3. Impact of the new rectal cancer definition on multimodality treatment and interhospital variability: Results from a nationwide cross-sectional study
4. Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment
5. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
6. Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting
7. Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome
8. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
9. Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors
10. Aggressive versus indolent insulinomas - new clinicopathological insights
11. Reply to 'von Hippel-Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement'
12. Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training
13. Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors
14. Multidisciplinary integrated care pathway for von Hippel–Lindau disease
15. Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring
16. Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors
17. Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
18. Metastatic patterns of duodenopancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1
19. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
20. The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up Analysis
21. Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
22. A Parathyroid-Gut Axis: Hypercalcemia and the Pathogenesis of Gastrinoma in Multiple Endocrine Neoplasia 1
23. Genome methylation accurately predicts neuroendocrine tumor origin - an online tool
24. The management of neuroendocrine tumors of the lung in MEN1: results from the Dutch MEN1 Study Group
25. Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration
26. The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: Report of 2 cases
27. Genomic characterization of malignant progression in neoplastic pancreatic cysts
28. Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas
29. Clear cell chondrosarcoma in Von Hippel-Lindau disease
30. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM)
31. Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers
32. Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (Nature Medicine, (2019), 25, 8, (1260-1265), 10.1038/s41591-019-0493-4)
33. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
34. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival
35. The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer
36. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment
37. A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
38. Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial): a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)
39. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)
40. Successful treatment of leptomeningeally metastasised pituitary carcinoma with temozolomide
41. Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas
42. Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin Organization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.